Characteristics of patients with type 2 diabetes of short duration in Poland: Rationale, design and preliminary results of the ARETAEUS1 study

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 9, 2009, Pages 533-540

  Bała, Małgorzata M ^a,b   Płaczkiewicz Jankowska, Ewa ^a   Topór Ma̧dry, Roman ^b   Leśniak, Wiktoria ^a,b   Wiercińska, Ewa ^b   Szczepaniak, Paulina ^a   Jaeschke, Roman ^c   Sieradzki, Jacek ^b   Grzeszczak, Władyslaw ^d   Banasiak, Waldemar ^e  

^a Polish Institute of Evidence Based Medicine   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c MCMASTER UNIVERSITY   (Canada)

^d MEDICAL UNIVERSITY OF SILESIA   (Poland)

^e MILITARY HOSPITAL   (Poland)

Author keywords

Clinical practice guidelines; Cross sectional study; Diabetes control; Type 2 diabetes

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIAC PATIENT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; DIABETES CONTROL; DIABETIC FOOT; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; GENERAL PRACTITIONER; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; POLAND; PRACTICE GUIDELINE; QUESTIONNAIRE; STROKE; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 70349964573     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.761     Document Type: Article

References (36)

1. IDF Worldwide Definition of the Metabolic Syndrome. International Diabetes Federation. http://www.idf.org. Accessed Oct 16, 2008.
2. Sieradzki J. [Diabetes and metabolic syndrome]. In: Szczeklik A. ed. (Internal medicine. Evidence-based multimedia manual]. Kraków, Medycyna Praktyczna, 2005. Polish.
3. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358: 2545-2559.
4. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008; 358: 2560-2572.
5. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009; 360: 129-139.
6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UK-PDS 33). Lancet. 1998; 352: 837-853.
7. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998; 352: 854-865
8. Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008; 359: 1577-1589.
9. Szurkowska M, Szafraniec K, Gilis-Januszewska A, et al. [Prevalence of the glucose metabolism disturbances in screening of adult inhabitants of Krakow]. Przegl Lek. 2006; 63: 728-732. Polish.
10. Wójcikowski C, Sieradzki J, Grzeszczak W, et al. [Screen-Pol I: Polish study for early detection of type 2 diabetes - objectives and assumptions of Screen-Pol program]. Diabetologia Polska. 1999; (Suppl 6) 2: 165-177. Polish.
11. Wójcikowski C, Grzeszczak W, Sieradzki J, et al. [Screen-Pol II: Diagnosis of type 2 diabetes according to WHO and ADA diagnostic criteria in Screen-Pol study]. Diabetologia Polska. 1999; (Suppl 6) 2: 178-186. Polish.
12. Grzeszczak W, Wójcikowski C, Sieradzki J, et al. [Screen-Pol III: Early detection of type 2 diabetes mellitus observed during Polish Screen-Pol study. Regional differences]. Diabetologia Polska. 1999; (Suppl 6) 2: 187-208. Polish.
13. Sieradzki J, Grzeszczak W, Wójcikowski C, et al. [ScreenPol IV: Risk factors and sympthoms and prevalence of diabetes in Screen-Pol study]. Diabetologia Polska. 1999; (Suppl 6) 2: 209-220. Polish.
14. Fabian W, Majkowska L, Stefański A, et al. [Prevalence of diabetes, provided antidiabetic treatment and chronic diabetic complications reported by general practitioners]. Przegl Lek. 2005; 62: 201-205. Polish.
15. Fabian W, Majkowska I, Stefański A, et al. [Assessment of the prevalence of diabetes and diabetic complications reported by general practitioners]. Diabetologia Doświadczalna i Kliniczna. 2004: 4: 31-34. Polish.
16. Wa̧growska H, Rywik S. [Prevalence of hypertension in the population of the right-bank Warsaw districts based on research from the Pol-Monica study]. Wiad Lek. 1990; 43: 47-55. Polish.
17. Broda G, Sznajd J, Rywik S, et al. [Hypertension - diagnosis, treatment and the effectiveness of the treatment of Polish population participating in the POL-MONICA program]. Przegl Lek. 1990; 47: 473-478. Polish.
18. Tykarski A, Posadzy-Małaczyńska A, Wyrzykowski B, et al. [Prevalence of hypertension and efficacy of its treatment in adult inhabitants of our country. Results of WOBASZ program]. Kardiol Pol. 2005; 63; S614-S619.
19. Zdrojewski T, Bandosz P, Szpakowski P, et al. [Prevalence of main cardiovascular risk factors in Poland. Results of NATPOL PLUS study]. Kardiol Pol. 2004; 61 (Suppl 4): 15-17. Polish.
20. Biela U, Paja̧k A, Kaczmarczyk-Chałas K, et al. [Prevalence of overweight and obesity in females and males 20-74 years old. Results of WOBASZ Program]. Kardiol Pol. 2005; 63: S632. Polish.
21. Rywik S, Paja̧k A, Broda G, et al. [Prevalence of overweight and obesity in selected populations in Poland - Pol-MONICA Bis Project]. Medycyna Metaboliczna. 2003; 2: 8-15. Polish.
22. Paja̧k A, Wiercińska E, Polakowska M, et al. [Prevalence of dyslipidemia in males and females aged 20-74. Results of WOBASZ program]. Kardiol Pol. 2005; 63, 620-625. Polish.
23. Jóźwiak J, Mastej M. Lukas W, et al. [Assessment of incidence of the metabolic syndrome components in patient population treated for dyslipidemia. Polish national epidemiologic study LIPIDOGRAM 5 YEARS]. Problemy Medycyny Rodzinnej. 2008: 10: 63-67. Polish.
24. Broda G, Szcześniewska D, Rywik S. [Prevalence of metabolic syndrome in adult population of Warsaw]. Medycyna Metaboliczna 2003; 2: 25-29. Polish.
25. Wyrzykowski B, Zdrojewski T, Sygnowska E, et al. [Epidemiology of metabolic syndrome in Poland. Results of WOBASZ program]. Kardiol Pol. 2005; 63: 6 (Suppl 4): S1-S4. Polish.
26. Sieradzki J, Grzeszczak W, Kasperska-Czyżyk T, et al. [The DINAMIC 2 study: aims, assumptions and methods (I)]. Diabetologia Praktyczna. 2003; 4: 97-102. Polish.
27. Sieradzki J, Kasperska-Czyżyk T, Grzeszczak W, et al. [The DINAMIC 2 results in Poland (II)]. Diabetologia Praktyczna. 2003; 4: 103-111. Polish.
28. Grzeszczak W, Sieradzki J, Kasperska-Czyżyk T, et al. [DINAMIC 2 study: results of comparison among various regions of Poland (III)]. Diabetologia Praktyczna. 2003; 4: 111-124. Polish.
29. Sieradzki J, Grzeszczak W, Kamafel W, et al. [The PolDiab Study. Part I. Analysis of diabetes treatment in Poland]. Diabetologia Praktyczna. 2006; 7: 8-15. Polish.
30. 1c screening in 2002 and 2005]. Diabetologia Praktyczna. 2008; 9: 132-139. Polish.
31. Sieradzki J, Nazar M. [Intensification of insulin therapy in Poland. Basic parameters of metabolic control and treatment satisfaction - results of a large trial of patients with type 2 diabetes - Polish]. Diabetologia Praktyczna. 2004; 5: 173-182. Polish.
32. Andel M, Grzeszczak W, Michalek J, et al. [A multinational, multi-centre, observational, cross-sectional survey assessing diabetes secondary care in Central and Eastern Europe (DEPAC Survey)]. Diabetologia Medyczna. 2008; 25: 1195-1203. Polish.
33. Polish Diabetes Association. [Clinical recommendations for the management of patients with diabetes 2008. Statement of Polish Diabetes Association]. Med Prakt. 2008; 4: 1-58.
34. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008; 31 (Suppl 1): S55-S60.
35. Alberti G, Zimmet S, Shaw J, et al. The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org. Accessed October 16, 2008.
36. American Diabetes Association Standards of Medical Care in Diabetes 2009. Diabetes Care. 2009; 32: S13-S61.